Take a trial of UK to unlock this pageFind out more

This company is no longer active. Data may be out of date or incorrect.
Momentum
Relative Strength (%)
1m
3m
1yr
Volume Change (%)
10d v 3m
Price vs... (%)
52w High
50d MA
200d MA
vs.
market
vs.
industry
Growth & Value
Margin of Safety (beta)
Screens Passed
Balance Sheet · Income Statement · Cashflow Financial Summary
Year End 30th Sep 2009 2010 2011 2012 2013 2014 2015E 2016E CAGR / Avg
Revenue $m
Operating Profit $m
Net Profit $m
EPS Reported $
EPS Normalised $
EPS Growth %
PE Ratio x
PEG x
Profitability
Operating Margin %
ROA %
ROCE %
ROE %
Cashflow
Op. Cashflow ps $
Capex ps $
Free Cashflow ps $
Dividends
Dividend ps $
Dividend Growth %
Dividend Yield %
Dividend Cover x
Balance Sheet
Cash etc $m
Working Capital $m
Net Fixed Assets $m
Net Debt $m
Book Value $m
Average Shares m
Book Value ps $ +17.2%

FINANCIAL BRIEF: For the fiscal year ended 30 September 2014, Optos Plc revenues increased 7% to $168.9M. Net income increased 33% to $8.5M. Revenues reflect USA segment increase of 17% to $115.9M. Net income benefited from Administrative and other expenses decrease of 12% to $45.5M (expense), Other Non Rec. I/E - Non Business Activ decrease of 36% to $900K (expense). Basic Earnings per Share excluding Extraordinary Items increased from $0.09 to $0.12. more »

Health Trend
Bankruptcy Risk
  Earnings Manipulation Risk
Magic Formula Score
Other Ratios
Leverage (ttm) Total Ex Intang
Gross Gearing %
Net Gearing %
Cash / Assets %
vs.
market
vs.
industry
Recent History
Latest interim period (ended 30th Sep '14) vs. prior year
Sales Growth %
EPS Growth %
3yr Compound Annual Growth Rate
Sales Growth %
EPS Growth %
DPS Growth %

Broker Forecasts
30th Sep 2015
30th Sep 2016

Price Target: $4.72
(-10.81% below Price)
Net Profit EPS DPS Net Profit EPS DPS
Est. Long Term Growth Rate: n/a ($) (¢) (¢) ($) (¢) (¢)
Consensus Estimate
1m Change
3m Change
4 brokers Broker Consensus Trend
Broker Recommendations for Optos
Recommendation:Strong SellSellHoldBuyStrong Buy
No. of Analysts: 0 0 3 1 1

Named Brokers and Analysts
Jefferies Ingeborg Oie , Investec Bank (UK) Plc Nicholas Keher , Canaccord Genuity , Panmure Gordon Savvas Neophytou , Numis Securities Charles Weston , Peel Hunt , N+1 Singer Elizabeth Klein Chris Glasper , Shore Capital Stockbrokers ,

Profile Summary

Optos plc is a medical retinal imaging company. The Company is a provider of devices and solutions to eyecare professionals for improved patient care. The Company's core devices produce ultra widefield, high resolution digital images (optomaps) of approximately 82% of the retina. The Company is a provider of diagnostic and treatment devices for eyecare professionals, with Ultra-widefield (UWF) Retinal Imaging. The Company's product range includes ultra-widefield imaging, OCT, visual acuity, perimetry and treatment laser products. The Company has a range of imaging devices that support different patient levels. The Company's widefield retinal imaging technology, combined with data from OCT images, offers ophthalmologists and optometrists the tools for disease discovery and management. The Company is a provider of devices for diagnosing and treating diseases, and conditions present in the retina of the eye.

No Management Information.

No. of Employees: 391 No. of Shareholders: n/a


Last Annual September 30th, 2014
Last Interim September 30th, 2014
Incorporated August 26, 1992
Public Since February 9, 2006
Shares in Issue 75,964,957
Free Float 63.9m (84.2%)
Sector Healthcare
Industry Healthcare Equipment & Supplies
Index
Exchange London Stock Exchange
Eligible for an ISA? a SIPP?

Use of our data service is subject to express Terms of Service. Please see our full site disclaimer for more details. In particular, it is very important to do your own research (DYOR) and seek professional advice before making any investment based on your own personal circumstances. Please note that the information, data and analysis contained within this stock report: (a) include the proprietary information of Stockopedia's third party licensors and Stockopedia; (b) should not be copied or redistributed except as specifically authorised; and (c) are not warranted to be complete, accurate or timely. You should independently research and verify any information that you find in this report. Stockopedia will not be liable in respect of any loss, trading or otherwise, that you may suffer arising out of such information or any reliance you may place upon it. Past performance is no guarantee of future results. The value and income derived from investments may go down as well as up. © Stockopedia 2015.


Should you buy OPTS

Access OPTS Analytics Now!

FREE TRIAL or TAKE THE TOUR
Let’s get you setup so you get the most out of our service
Done, Let's add some stocks
Brilliant - You've created a folio! Now let's add some stocks to it.

  • Apple (AAPL)

  • Shell (RDSA)

  • Twitter (TWTR)

  • Volkswagon AG (VOK)

  • McDonalds (MCD)

  • Vodafone (VOD)

  • Barratt Homes (BDEV)

  • Microsoft (MSFT)

  • Tesco (TSCO)
Save and show me my analysis
Foliobuilder